As reported through the article titled, "safety and efficacy results of the flow redirection endoluminal device (fred) stent system in the treatment of intracranial aneurysms: us pivotal trial", after undergoing aneurysm treatment with a fred stent, 4 patients developed device thrombosis on post-treatment days 1, 3, 5 and 345.Three of these four delayed events were thought to be due to technical problems, including carotid dissection and kinking of the device, and the fourth, noted on day 345, was seen in the setting of multiple territory thrombo-embolic infarcts.Two of these four patients with delayed events had complete occlusion of the parent artery.".
|